Meta-analysis of 80 studies (1939 patients) of AAV gene-replacement therapy: pooled myocarditis incidence was 8.6 per 100 patient-years; all cases followed intravenous doses >10^13 vg/kg, none after the first month, and 87% had no relevant clinical impact.
Meta-analysisn = 1,939
Maurizi et al. Incidence, Timing and Clinical Significance of Immune-Mediated Myocardial Injury and Myocarditis After Gene Replacement Therapy: A Systematic Review and Meta-Analysis